For more than 1130 years, we have brought hope to humanity through the development of important medicines and vaccines. We aspire to be the premier research-intensive biopharmaceutical company in the world — and today, we are at the forefront of research to deliver innovative health solutions that advance the prevention and treatment of diseases in people and animals.
We are committed to making BioJohnson Global Services a better place to work. Our people are at the heart of everything we do, and we believe strongly in making their working life enjoyable, productive and worthwhile. In recent years we have launched numerous initiatives to improve our working environment
BioJohnson Global Services works actively with the scientific community, patient groups and payers to ensure our therapies reach the right patient at the right time and with the right level of care. But we take our wider responsibilities seriously, too – both from a CSR and a regulatory perspective.
We believe it is no longer enough for companies to focus solely on drug development. Our goal is to provide a holistic solution both to patients and also the wider healthcare community.
Our years of experience in Parkinson’s and other movement disorders have made us experts in patient therapy, but we are also committed to supporting our entire treatment programmes.
Our dedicated nursing team works closely with the NHS and other healthcare professionals to provide specialist care in complex disease areas. The nurses ensure families and carers are given the knowledge they need to better understand the treatments patients are receiving.
At all levels of our organisation, we are committed to providing quality of life to patients, value to payers and medical support to prescribers.